Research Article

Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size

Table 2

Patient base-line characteristics.

CharacteristicTCM user group(N=32)non-TCM user group(N=35)p

Sex, (%)
 Male21 (65.62)26(74.29)
 Female11(34.38)9(25.71)0.439
Age, yr, (%)
 ≤505(15.63)5(14.29)
 50-6520(62.50)20(57.14)
 >657(21.87)10(28.57)0.820
Smoking status, (%)
 Never smoked12(37.50)12(34.29)
 <40014(43.75)12(34.29)
 ≥4006(18.75)11(31.42)0.474
ECOG performance status score—no. (%)
 002(5.71)
 127(84.38)27(77.14)
 25(15.62)6(17.14)0.375
Tumor size, (%)
 <5cm14(43.75)17(48.57)
 ≥5cm18(56.25)18(51.43)0.693
Histologic diagnosis, (%)
Adenocarcinoma23(71.88)21(60.0)
Squamous-cell carcinoma9(28.12)12(34.28)
Adenosquamous carcinoma01(2.86)
Other01(2.86)0.496
Clinical stage, (%)
 IIA6(18.75)13(37.14)
 IIB14(43.75)9(25.71)
 IIIA12(37.50)13(37.14)0.167
modus operandi, (%)
 thoracotomy17(53.13)18(51.43)
 Thoracoscopy minimally invasive14(43.75)15(42.86)
 Combined1(3.12)2(5.71)0.877